Estonia Invests €5M to Genotype 100K People in 2018 as Part of Personalized Medicine Project

Dec 21, 2017

|

NEW YORK (GenomeWeb) – The Estonian government announced this week that it has allocated €5 million ($5.9 million) to support the genotyping of 100,000 people in the Northern European country next year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

After Your Number

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Not Quite How It Works

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Research, But Not in Name

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

Science Finds Support for Gene Drives Depends on Species Targeted, Ability to Control Drive; More

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.

Featured White Papers

The 'Dark Matter' of Cancer Genomics: Revealing Undetected Structural Variants in Leukemia White Paper

Investigating the Human Immune Response with Myriad RBM’s TruCulture System and the NanoString nCounter Autoimmune Profiling Panel

Measuring DNA Concentration with Less Time and More Accuracy

Sample Normalization with RNAGEM

Oct

23

Featured Webinar

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.

Oct

24

Featured Webinar

Designing, Decoding & Delivering on Genetic Testing for Inherited Disease at Versiti

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

Menu